Is Concord Medical Services Holdings Limited (CCM) a Buy, Sell, or Hold?
NYSE : CCM
Concord Medical Services Holdings Limited — News
$5.18 USD
$0.84 (19.35%)
- Volume
- 93.58K
- Average Volume
- 44.39K
- Market Capitalization
- $754.28K
- P/E Ratio
- -0.04
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $6.98
- Year Low
- $3.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.48
| Source | Headline |
|---|---|
|
TWO Urges Stockholders to Vote FOR the CCM Transaction Today; Failure to Approve Risks a Significant Decline in TWO's Stock Price
NEW YORK--(BUSINESS WIRE)--TWO Urges Stockholders to Vote FOR the CCM Transaction Today; Failure to Approve Risks a Significant Decline in TWO's Stock Price. businesswire.com - 2026-06-22 07:00:00 |
|
ComplianceCow to Demonstrate Generative AI-Powered CCM 3.0 Controls in ServiceNow IRM
SAN FRANCISCO--(BUSINESS WIRE)--ComplianceCow, an agentic automation platform for enterprise security GRC teams, will host a live webinar on June 22, 2026 demonstrating how Generative AI transforms natural language inputs into deterministic, auditable Continuous Controls Monitoring (CCM) 3.0 controls inside ServiceNow IRM. The session, titled From Prompt to Production: Building Automated CCM 3.0 Controls with Generative AI in ServiceNow IRM, runs from 1:30 to 2:00 pm ET and is open to complianc. businesswire.com - 2026-06-11 11:00:00 |
|
RegScale Achieves ISO 27001 Certification in Under 30 Days Using Its Own Continuous Controls Monitoring Platform
TYSONS, Va.--(BUSINESS WIRE)--RegScale, the AI-powered continuous controls monitoring (CCM) platform, today announced it has achieved ISO 27001 certification in under 30 days using its own Continuous Controls Monitoring (CCM) platform. For most organizations pursuing certification through manual processes, the journey runs around six months. RegScale's result demonstrates what becomes possible when compliance runs continuously: certification is a byproduct of the program, not a project of its o. businesswire.com - 2026-06-11 08:20:00 |
|
Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Highlights: According to third-party industry reports, the U.S. RPM market is currently $14 Billion alone and expected to reach approximately $29 Billion by 2030, representing a 12.6% CAGR, as healthcare providers continue shifting toward value-based and home-based care models¹ Pilot initiative launched across multiple provider offices focused on chronic care management (CCM) and remote patient monitoring (RPM) through it's MSO infrastructure Approximately 1,500+ claims generated to date through the pilot infrastructure with expansion roadmap targeting additional providers Wellgistics Pharmacy Network of 6,500+ independent pharmacies positioned to support patient engagement and care coordination initiatives Participating pharmacists expected to gain access to new clinical service revenue opportunities TAMPA, FL / ACCESS Newswire / May 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced a pilot collaboration with Kare PharmTech and Kare Clinicals integrating its MSO infrastructure to support chronic care management ("CCM") and remote patient monitoring ("RPM") services across participating provider offices. According to third-party industry reports, the U.S. RPM market is currently $14 Billion and expected to reach approximately $29 Billion by 2030, representing a 12.6% CAGR, as healthcare providers continue shifting toward value-based and home-based care models. accessnewswire.com - 2026-05-13 09:05:00 |
